Culture conditions suitable for specific sensitization of human peripheral blood lymphocytes were established. Production of antibody to sheep erythrocytes and to the 2,4,6-trinitrophenyl group conjugated to burro erythrocytes was investigated in terms of cross-sensitization, feedback control by antibody to the immunogen, and regulation by helper and suppressor T cells. Generation of antigen-specific antibodyforming cells was found to be restricted to a narrow concentration range of cultured peripheral blood lymphocytes. The data suggest that antibody formation is limited by suppressor T cells in high-cell-density cultures and by low frequencies of helper T cells in low-cell-density cultures.
The knowledge of the mechanisms that govern the humoral immune response has been greatly advanced by the culture technique, initially developed by Mishell and Dutton (1) for murine spleen cells, that permitted the study of antibody production in vitro. Application of the same technique to the study of human lymphocytes has been less successful. Although tonsil (2) and spleen cells (unpublished data) have been shown to produce antibody against sheep erythrocytes (SRBC) in vitro under conditions similar to the conditions commonly used in experiments with murine spleen cells, peripheral blood lymphocytes (PBL) did not produce antibody when cultured and tested in the same way (2) . Because PBL represent the only lymphocytes that are readily accessible, progress in the study of the humoral immune response in man has been hampered by the lack of a technique that permits in vitro sensitization of PBL. If one disregards the well-established assay that measures the polyclonal production of antibody not dependent on antigen (3) , success has been reported only by two groups. In the first case (4) , infection with the Epstein-Barr virus was required to enable PBL to produce antibody in specific response to SRBC or horse erythrocytes (HRBC). In the second case (5) , no additional stimulus was used but the hemolytic plaques were so small that their identity with the hemolytic plaques in the standard assay has been questioned. I report here that human PBL can be induced to produce antibody against erythrocyte antigens in vitro under Mishell-Dutton culture conditions when (i) a proliferative stimulus is provided, (ii) human serum is added to the culture medium with a delay of 20-24 hr, and (iii) B-cell differentiation to antibody-secreting cells is supported by addition of a macrophage-produced B-cell differentiating factor (BDF).
MATERIALS AND METHODS Reagents. SRBC, burro erythrocytes (BRBC), and HRBC were obtained from the Colorado Serum Company (Denver, CO). Erythrocytes were derivatized with the 2,4,6-trinitrophenyl group (TNP) as described (6) . Staphylococcus aureus, Cowan I strain (ATCC 1285), was cultured and heat-inactivated as described (7) . Rabbit anti-SRBC IgG (no. 678-970) and anti-SRBC IgM (no. 678-990) were purchased from Cordis (Miami, FL). Concanavalin A (Con A; A grade; lot 610049) was purchased from Calbiochem. Mitomycin C (cat. M-0503) was obtained from Sigma.
Preparation of PBL. Heparinized human blood was diluted with an equal volume of balanced salt solution (1), layered over 15 ml of Ficoll/Hypaque (Lymphoprep, Nyegaard, Oslo, Norway) in 50-ml plastic centrifuge tubes (Falcon, no. 2070), and centrifuged for 30 min at 400 X g at room temperature. PBL were collected from the interface, washed twice with Eagle's minimal essential medium, and resuspended in complete Mishell-Dutton culture medium (1) .
Preparation of Monocyte-Conditioned Medium (MCM) Containing BDF. MCM was produced as described (8) . PBL (5 X 106) were incubated at 370C for 50 min in complete Mishell-Dutton medium containing 20% fetal calf serum to allow monocytes to adhere to the bottom of the culture dish. The nonadherent cells were subsequently removed by extensive washing and the remaining adherent cells (primarily monocytes) were incubated in serum-free Mishell-Dutton culture medium in the presence of 1 g of lipopolysaccharide (derived from S. abortus equi and provided by Chris Galanos, Freiburg, Germany) per ml. Culture supernatants were harvested 24 hr later, centrifuged for 10 min at 2000 rpm, passed through Millipore filters (0.45,um), and stored at -70°C until used. The BDF activity of monocyte culture fluids was assessed as described (8) .
Cultures. PBL were suspended in complete Mishell-Dutton culture medium which contained, in addition, 50 ,um 2-mercaptoethanol. Fetal calf serum (lot 94055) was obtained from Microbiological Associates (Walkersville, MD). Among 14 samples tested, this batch was found most suitable for this study because it supported specific antibody formation and induced low background responses. (Fetal calf serum that supported antibody formation in murine spleen cell cultures also supported the response of human PBL in vitro.) PBL in different concentrations in 0.1-ml volumes were placed in flat-bottom mi- 288 0 280 PBL were cultured at different cell concentrations (6 X 104 to 5 X 105 per culture) and immunized with SRBC or BRBC-TNP. The cell concentration yielding optimal anti-SRBC response was determined in control cultures (no addition of antibody), and the data presented for the experimental culture (antibody added) were obtained from cultures containing the same number of PBL. Each value was determined from a pool of eight cultures. pressor cells in the regulation of antibody production in the mouse. To determine if T cells have a helper function in the production of antibody by human PBL, they were separated on the basis of their ability to form rosettes with SRBC (9) and the production of antibody by the resetting fraction (T cells), the nonrosetting fraction (containing B cells), and the combined fractions was tested. The combined fractions produced anti-TNP antibody, but the resetting fraction or the nonrosetting fraction alone did not ( Table 3 ). The resetting (T cell) fraction alone produced antibody to SRBC, but this could be related to the presence of some SRBC-specific B-cell precursors that also formed rosettes with SRBC because they carry receptors for SRBC antigens.
Participation of T cells in the production of antibody by human PBL was also shown in experiments which tested the effects of Con A. Con A is known to activate suppressor T cells and helper T cells in the mouse (12) . Initial experiments indicated that Con A had similar effects on cultures of human PBL (Table 4) . Con A inhibited antibody formation when added to the cultures immediately but enhanced antibody formation when added 1 or 2 days after sensitization. This finding is consistent with observations made with cultured murine spleen cells which show that suppressor T cells are effective only in the early phase (13) of culture whereas Con A-stimulated helper T cells [or a T-cell replacing factor (TRF) released by them] are most effective when added as late as on the second day of culture (14) .
In addition to being time-dependent, the net effect of Con A depends on the density of murine spleen cells in culture. Although antibody production is suppressed by Con A at high cell density, marked stimulation has been seen at low cell density (12) . We observed similar effects of Con A in cultures of human PBL. In the experiment shown in Fig. 4A , human PBL produced antibody against SRBC when cultured at concentrations of 1.2 X 105 to 5 X 105 cells per culture. The response was abrogated by addition of Con A on day 0. By contrast, cultures at lower cell density (3 X 104 cells) that did not respond in the absence of Con A produced antibody when Con A was added. The fact that Con A induced antibody formation in cultures at low cell density suggested that these cultures contain adequate numbers of precursor B cells and that it is an insufficient number of helper T cells which limits the response.
To test this possibility I made use of the fact that helper T cells are less sensitive to radiation (12) or treatment with mitomycin C (15) than are suppressor T cells: mitomycin C-treated autologous PBL were added as a source of helper T cells to the PBL cultures (Fig. 4B) . Whereas mitomycin-treated PBL alone did not significantly alter the response of PBL, addition of Con A enhanced antibody formation markedly as compared with cultures to which mitomycin-treated PBL had not been added, particularly low density cultures. In high-density cultures this effect was obscured, probably because a large number of suppressor cells were generated by early addition of Con A in the population that was not treated with mitomycin.
These findings support the view that the production of antibody by PBL is limited by suppressor T cells in PBL cultures of high cell density and by helper T cells in low-density cultures. Allogeneic mitomycin C-treated PBL had the same effect as autologous mitomycin-treated PBL (Fig. 4C) . (Allogeneic cells occasionally enhanced the response when added in the absence of Con A; this enhancement was obscured, however, by the response induced in the presence of Con A.) The mixed culture approach is applicable to the dissection of immune defects in patients with primary or secondary immune deficiencies. It is possible to determine, for example, the ability of mitomycintreated PBL from such patients to generate helper signals in the presence of Con A or the ability of their B cells to respond to helper signals provided by mitomycin-treated PBL from normal donors. Similarly, the presence of suppressor T cells can be demonstrated and their proportions estimated.
DISCUSSION
These experiments were based on the premise that human PBL (i) contain all cellular elements that are required for the antigen-dependent production of antibody, and (ii) fail to produce antibody in response to antigen in vitro because the proportional representation of these cellular elements is different from their representation in the cell populations of tonsil and spleen [which produce antibody in vitro (2)]. The first assumption is supported by the facts that human PBL can be induced to produce antibody to SRBC in vitro by stimuli that cause a polyclonal response (3) and that antigen-dependent production of antibody to SRBC can be induced by subjecting the B lymphocyte population to the additional stimulus of infection with Epstein-Barr virus (4). In these experiments, addition of S. aureus (which induces proliferation of B lymphocytes) (16) and BDF (which supports differentiation of B lymphocytes (6, 14, 17, 18) was effective in supporting the antigen-dependent production of antibody by PBL. As for the second assumption, it must be kept in mind that B lymphocytes represent only a small fraction (approximately 8%) of PBL, far outnumbered by the T lymphocyte fraction and, of course, susceptible to regulation by helper and suppressor T cells. Studies in the mouse indicate that an increase in proportion of T helper and suppressor lymphocytes-as occurs, for example, after stimulation with T-cell mitogen (12) in vitro or with alloantigen (19)-changes the balance in favor of suppressor cell activity. Increased helper cell activity can often be demonstrated after removal of suppressor T cells (13, 20) unless the spleen cells are cultured at very low density (12, 13) ; at higher cell density, increased suppressor cell activity completely obscures the increased helper cell activity. These findings led to study of antibody production by cultures of human PBL at various cell densities. The results are compatible with the concept that the failure of human PBL to produce antibody against erythrocyte antigen in cultures of high cell density is caused by suppressor cells. The mechanism by which suppressor T cells inhibit the production of antibody by.B cells is not completely understood. The observation that cultures of human PBL produce antibody in flat-bottom wells but not in round-bottom wells, where cell contact is closer, supports the view that close proximity among cultured PBL or cell-to-cell contact is necessary for optimal suppressor T cell activity. When I have been concerned with the possibility that hemolytic plaques observed in the assays were identical with "pseudoplaques" caused by antibody present in human AB serum that was added to the cultures. Muchmore et al. (19) have shown that, of 14 human plasmas examined, 3 led consistently to the formation of pseudoplaques in cultures of human PBL. These plaques are not the result of active antibody synthesis but the result of carry-over of aggregates of antibody-coated erythrocytes and subsequent release of this antibody in the hemolytic plaque assay. When the human plasma used to supplement the culture medium was absorbed with antigen before culture, all pseudoplaque formation was abrogated. I therefore extensively absorbed with antigen the four batches of human serum used in these experiments. The response of human PBL to SRBC and to BRBC-TNP was found to be unaffected by this procedure. I have subsequently used unabsorbed human serum to supplement PBL cultures in order to avoid a possible antigen transfer with absorbed sera into antigen-negative control cultures.
Culture at varying cell density, addition of Con A, and addition of mitomycin-treated autologous or allogeneic PBL were useful manipulations in experiments designed to determine the role played by B cells, helper T cells, and suppressor T cells in the production of antibody. The balance was found to be in favor of suppressor T cells in cultures at high cell density, an effect that was accentuated by early addition of Con A. Once the production of antibody had been initiated in such cultures, delayed addition' of Con A caused no suppression. Apparently, the necessary proliferation of suppressor cells occurred too late to be effective. In cultures of low cell density, early addition of Con A enhanced rather than suppressed the production of antibody. It seems that the activation of helper T cells outweighed the activation of suppressor T cells under low-density conditions. A means of providing a sufficient number of helper T cells in low-density cultures has been the addition of autologous or allogeneic PBL treated with mitomycin. T-cell helper function [which does not depend on proliferation (12)] is.not affected by mitomycin, whereas the development of suppressor T cells and antibody-secreting B cells [which depends on proliferation (12)1 is inhibited. The mixed culture approach will be of particular importance in dissecting defects in the humoral immune response of patients with primary or secondary immunodeficiency.
